To evaluate the prime reasons for initiation Canakinumab in the United States in Patients with Periodic Fever syndromes : A Retrospective Medical Chart Review
Latest Information Update: 07 Feb 2020
At a glance
- Drugs Canakinumab (Primary)
- Indications Cryopyrin-associated periodic syndromes; Familial Mediterranean fever; Hereditary autoinflammatory diseases
- Focus Therapeutic Use
- 07 Feb 2020 New trial record